Alberta Purchasing #AB-2026-07096

HealthPRO Canada Award for Hospital-Specific Injectable Pharmaceuticals

HealthPRO Canada announced an award for hospital-specific injectable pharmaceuticals under contract cycle PH24. - Buyer and procurement organization: HealthPRO Procurement Services Inc. (HealthPRO Canada), serving healthcare institutions. - Award: Off-patent, hospital-specific injectable pharmaceutical products, primarily for healthcare institutions; specific drug names, manufacturers, part numbers, and quantities are not provided. - Named organizations: HealthPRO Procurement Services Inc. (HealthPRO Canada) is the procurement organization. Euna is identified as the platform for future amendments. No pharmaceutical OEMs or product vendors are named. - Award value: 2,804,772; the notice does not specify the currency. - Notable requirement: The procurement concerns off-patent injectable products intended for hospital use. - Period of performance: Not specified in the available notice.

Description

This award notice covers a contract for off-patent, hospital-specific injectable pharmaceutical products used primarily by healthcare institutions. The notice identifies contract cycle PH24 and lists four awarded suppliers: Sterinova Inc., Fresenius Kabi, SteriMax Inc., and Hikma Canada Ltd. The award notice total value and actual value are both 2,804,772. HealthPRO says interested parties may email rfpinquiriesph@healthprocanada.com for secure access to the opportunity, and future addenda or amendments will be posted on Euna.

View original listing